Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

In latest Pfizer COVID-19 ad, Martha Stewart asks: Got Booster?
Medical Marketing and Media
Fri, 01/13/23 - 10:51 am
Tags:
Pfizer, COVID-19, vaccines, boosters, celebrity endorsements, pharma advertising, DTC advertising
Former Pfizer exec Melissa Gunn wants to use data to transform the pharma industry as she joins Constellation
Medical Marketing and Media
Thu, 01/12/23 - 09:14 pm
Tags:
Melissa Gunn, Constellation, SaaS, Pfizer
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
Tags:
M&A, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, Ipsen, Merck, Pfizer
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
Reuters
Tue, 01/10/23 - 10:59 am
Tags:
Pfizer, Supreme Court, Medicare, kickbacks, Vyndaqel, Vyndamax
JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says
Fierce Pharma
Tue, 01/10/23 - 10:52 am
Tags:
JPMHC 2023, Pfizer, Pharma CEOs, Albert Bourla
JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies
BioPharma Dive
Tue, 01/10/23 - 10:47 am
Tags:
JPMHC 2023, vaccines, COVID-19, Moderna Therapeutics, Pfizer, Gilead Sciences
FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
Tags:
FDA, priority review, Pfizer, Prevnar 20, vaccines, Roche, bispecific antibodies, glofitamab, lymphoma
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Tags:
Pfizer, Merck, JNJ, Novo Nordisk, AstraZeneca
Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale
Fierce Biotech
Fri, 01/6/23 - 10:09 am
Tags:
Pfizer, R&D, externalization, gene therapy, Rare Diseases
Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax
Fierce Biotech
Thu, 01/5/23 - 10:14 am
Tags:
Moderna Therapeutics, RSV, GSK, Pfizer, vaccines
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Tags:
Pfizer, Merck, JNJ, Novartis, AbbVie, Roche
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
Tags:
legal, Astellas, Pfizer, Lexiscan, patents
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials, Alzheimer's disease, obesity, Huntington's disease, M&A, AstraZeneca, Daiichi Sankyo, Nimbus Therapeutics, Takeda, Eli Lilly, Sanofi, Regeneron, Moderna Therapeutics, Gilead Sciences, Pfizer, Roivant, Alnylam, uniQure
Weak data as booster for Comirnaty close off opportunity for Valneva's COVID-19 vaccine
Fierce Biotech
Tue, 01/3/23 - 10:25 am
Tags:
Valneva, Pfizer, BioNTech, vaccines, boosters, COVID-29
Pfizer says hemophilia B gene therapy controlled bleeding in key study
BioPharma Dive
Fri, 12/30/22 - 10:42 am
Tags:
Pfizer, gene therapy, hemophilia B, fidanacogene elaparvovec
FDA accepts BLA for Pfizer’s meningococcal vaccine candidate
Pharmaceutical Business Review
Fri, 12/30/22 - 10:36 am
Tags:
Pfizer, FDA, vaccines, meningococcal disease, MenABCWY
Pfizer Doubles Down on AI/ML to Bring Transformative Medicines to Patients
BioSpace
Wed, 12/21/22 - 12:38 pm
Tags:
Pfizer, artificial intelligence, machine learning, innovation
Pfizer advances diabetes, obesity drug hopeful into mid-stage testing
BioPharma Dive
Wed, 12/21/22 - 12:34 pm
Tags:
Pfizer, diabetes, obesity, PF-07081532, Sosei Heptares
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca, Daiichi Sankyo, Pfizer, Roche, CSL, uniQure, Novo Nordisk, Eli Lilly
Pfizer's Supreme Court challenge of US kickback law is 'far-fetched,' HHS says
Fierce Pharma
Thu, 12/15/22 - 11:15 pm
Tags:
Pfizer, legal, kickbacks, Supreme Court, rebates, Medicare

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.